Home Clinical Topics FDA approves generic Strattera for ADHD

FDA approves generic Strattera for ADHD

On May 30, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Read more 

LEAVE A REPLY

Please enter your comment!
Please enter your name here